Ragab, A.E.; Badawy, E.T.; Aboukhatwa, S.M.; Kabbash, A.; Abo El-Seoud, K.A.
In Vitro Characterization of Inhibitors for Lung A549 and Leukemia K562 Cell Lines from Fungal Transformation of Arecoline Supported by In Silico Docking to M3-mAChR and ADME Prediction. Pharmaceuticals 2022, 15, 1171.
https://doi.org/10.3390/ph15101171
AMA Style
Ragab AE, Badawy ET, Aboukhatwa SM, Kabbash A, Abo El-Seoud KA.
In Vitro Characterization of Inhibitors for Lung A549 and Leukemia K562 Cell Lines from Fungal Transformation of Arecoline Supported by In Silico Docking to M3-mAChR and ADME Prediction. Pharmaceuticals. 2022; 15(10):1171.
https://doi.org/10.3390/ph15101171
Chicago/Turabian Style
Ragab, Amany E., Ebtisam T. Badawy, Shaimaa M. Aboukhatwa, Amal Kabbash, and Kamilia A. Abo El-Seoud.
2022. "In Vitro Characterization of Inhibitors for Lung A549 and Leukemia K562 Cell Lines from Fungal Transformation of Arecoline Supported by In Silico Docking to M3-mAChR and ADME Prediction" Pharmaceuticals 15, no. 10: 1171.
https://doi.org/10.3390/ph15101171
APA Style
Ragab, A. E., Badawy, E. T., Aboukhatwa, S. M., Kabbash, A., & Abo El-Seoud, K. A.
(2022). In Vitro Characterization of Inhibitors for Lung A549 and Leukemia K562 Cell Lines from Fungal Transformation of Arecoline Supported by In Silico Docking to M3-mAChR and ADME Prediction. Pharmaceuticals, 15(10), 1171.
https://doi.org/10.3390/ph15101171
